Regeneron Pharmaceuticals
REGN
#249
Rank
ยฃ60.58 B
Marketcap
ยฃ554.21
Share price
0.62%
Change (1 day)
-27.26%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): ยฃ30.36

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is ยฃ29.57. In 2022 the company made an earnings per share (EPS) of ยฃ32.07 a decrease over its 2021 EPS that were of ยฃ60.50.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ30.36-5.31%
2022ยฃ32.07-47%
2021ยฃ60.50133.36%
2020ยฃ25.9269.13%
2019ยฃ15.33-14.44%
2018ยฃ17.92100.71%
2017ยฃ8.9331.78%
2016ยฃ6.7738.96%
2015ยฃ4.8772.55%
2014ยฃ2.83-17.55%
2013ยฃ3.43-44.98%
2012ยฃ6.23-422.54%
2011-ยฃ1.9392.13%
2010-ยฃ1.0149.41%
2009-ยฃ0.67-15.84%
2008-ยฃ0.80-36.88%
2007-ยฃ1.27-9.6%
2006-ยฃ1.404.12%
2005-ยฃ1.35-323.68%
2004ยฃ0.60-135.51%
2003-ยฃ1.69-24.38%
2002-ยฃ2.2456.35%
2001-ยฃ1.43187.3%
2000-ยฃ0.50-16%
1999-ยฃ0.59177.78%
1998-ยฃ0.21-35.71%
1997-ยฃ0.33-68.42%
1996-ยฃ1.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ยฃ11.20-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ3.25-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ14.61-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ11.15-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.96-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ2.52-91.49%๐Ÿ‡ซ๐Ÿ‡ท France